# Jonathan Slone

> Jonathan Slone is a Series C investor at CLSA backing Medical, Health Care and Neuroscience. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [CLSA](https://shizune.co/investors/profile/clsa)
- Total investments: 1
- Last investment: Aug 2018
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jonathan-slone-9085baba

Jonathan Slone is a Series C investor at CLSA focused on Medical and Health Care. Jonathan Slone - CEO @ CLSA

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Health Care | 1 | 100% |
| Neuroscience | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Akili Interactive Labs | Akili Interactive Labs their broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and psychiatry, including attention-deficit hyperactivity and disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD) and various inflammatory diseases. |  | Series C | Aug 09, 2018 |  |

1 of 1 investments shown.

## Co-investors
- [DG VENTURES](https://shizune.co/investors/profile/dg-incubation) — VC Fund, 1 deal together
- [Omidyar Technology Ventures](https://shizune.co/investors/profile/omidyar-technology-ventures) — VC Fund, 1 deal together

## About CLSA

VC Fund · Hong Kong, Hong Kong

CLSA is an investment bank that provides security brokerage and investment banking services.

5 contacts available at CLSA.

| Name | Title | Profile |
| --- | --- | --- |
| Andrew Riddick | Head of Research | https://shizune.co/investors/profile/andrew-riddick |
| Donald Skinner | Executive Chairman, CLSA Capital Partners | https://shizune.co/investors/profile/donald-skinner |
| Gary Coull | Founder | https://shizune.co/investors/profile/gary-coull |
| Jonathan Slone | CEO | https://shizune.co/investors/profile/jonathan-slone |
| Bofeng Hu | Director | https://shizune.co/investors/profile/bofeng-hu-ac6b |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Jonathan Slone invest in?

Jonathan Slone invests primarily in Medical, Health Care and Neuroscience startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jonathan Slone last invest?

The most recent investment recorded for Jonathan Slone closed in Aug 2018. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co